UnicoCell Biomed Co., Ltd. 6794.TWO Stock
UnicoCell Biomed Co., Ltd. Price Chart
UnicoCell Biomed Co., Ltd. 6794.TWO Financial and Trading Overview
| UnicoCell Biomed Co., Ltd. stock price | 80.4 TWD |
| Previous Close | 86.6 TWD |
| Open | 86.6 TWD |
| Bid | 84.2 TWD x N/A |
| Ask | 85.2 TWD x N/A |
| Day's Range | 84 - 86.9 TWD |
| 52 Week Range | 31 - 104 TWD |
| Volume | 178.13K TWD |
| Avg. Volume | 77.98K TWD |
| Market Cap | 3.61B TWD |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.56 TWD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
6794.TWO Valuation Measures
| Enterprise Value | N/A |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | N/A |
Trading Information
UnicoCell Biomed Co., Ltd. Stock Price History
| Beta (5Y Monthly) | N/A |
| 52-Week Change | 148.97% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 104 TWD |
| 52 Week Low | 31 TWD |
| 50-Day Moving Average | 79.25 TWD |
| 200-Day Moving Average | 53.96 TWD |
6794.TWO Share Statistics
| Avg. Volume (3 month) | 77.98K TWD |
| Avg. Daily Volume (10-Days) | 81.08K TWD |
| Shares Outstanding | 42.36M |
| Float | N/A |
| Short Ratio | N/A |
| % Held by Insiders | N/A |
| % Held by Institutions | N/A |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | N/A |
| Most Recent Quarter (mrq) | N/A |
| Next Fiscal Year End | N/A |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | N/A |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | N/A |
| Diluted EPS (ttm) | -2.24 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | N/A |
| Total Cash Per Share (mrq) | N/A |
| Total Debt (mrq) | N/A |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | N/A |
| Book Value Per Share (mrq) | N/A |
Cash Flow Statement
| Operating Cash Flow (ttm) | N/A |
| Levered Free Cash Flow (ttm) | N/A |
Profile of UnicoCell Biomed Co., Ltd.
| Country | Taiwan |
| State | N/A |
| City | Taipei |
| Address | No. 13-20, Minquan East Road |
| ZIP | 11494 |
| Phone | 886 2 2792 2699 |
| Website | https://www.unicocell.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
UnicoCell Biomed Co., Ltd. engages in the research and development of stem cell drugs, cell therapy technology, and regenerative medical services in Taiwan. It develops ELIXCYTE, which is in Phase 2 clinical trials for the treatment of osteoarthritis and chronic kidney disease. The company offers UnicoVial, a cryotube and drug container for cell therapy products, as well as provides testing services. UnicoCell Biomed Co., Ltd. is based in Taipei, Taiwan.
Q&A For UnicoCell Biomed Co., Ltd. Stock
What is a current 6794.TWO stock price?
UnicoCell Biomed Co., Ltd. 6794.TWO stock price today per share is 80.4 TWD.
How to purchase UnicoCell Biomed Co., Ltd. stock?
You can buy 6794.TWO shares on the Taipei Exchange exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for UnicoCell Biomed Co., Ltd.?
The stock symbol or ticker of UnicoCell Biomed Co., Ltd. is 6794.TWO.
Which industry does the UnicoCell Biomed Co., Ltd. company belong to?
The UnicoCell Biomed Co., Ltd. industry is Biotechnology.
How many shares does UnicoCell Biomed Co., Ltd. have in circulation?
The max supply of UnicoCell Biomed Co., Ltd. shares is 55.68M.
What is UnicoCell Biomed Co., Ltd. Price to Earnings Ratio (PE Ratio)?
UnicoCell Biomed Co., Ltd. PE Ratio is now.
What was UnicoCell Biomed Co., Ltd. earnings per share over the trailing 12 months (TTM)?
UnicoCell Biomed Co., Ltd. EPS is -1.56 TWD over the trailing 12 months.
Which sector does the UnicoCell Biomed Co., Ltd. company belong to?
The UnicoCell Biomed Co., Ltd. sector is Healthcare.